FindTrial
Sign In

A study on the effect of intermittent fasting in reducing the blood sugar level and number of medicines in type 2 diabetic patients.

Open label randomized controlled trial evaluating the effect of three months intermittent fasting on polypharmacy in patients with type II diabetes mellitus. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057784
Enrollment
60
Registered
2023-09-18
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Intermittent Fasting with standard of care: 12 weeks The participants, in the fasting group will be permitted to consume food between the hours of 7 AM to 3 PM (7 hours) with breakfast

Sponsors

Jawaharlal Nehru Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of either gender and between the age of 18-75 years 2.Confirm cases of Type 2 Diabetes mellitus with HbA1c > 8.0 taking = 2 anti-diabetic medication 3.Willing to perform intermittent fasting as per instructions. 4.Willing to give informed consent.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating females 2.Patients having history of any major cardiovascular or neurovascular event in past like CVA/Stroke 3.Patients with significant active liver or kidney diseases 4.Patients with history of any endocrinal diseases 5.Patients on chronic medication which are known to affect the glycemic status of the patient.

Design outcomes

Primary

MeasureTime frame
To assess the effect of intermittent fasting on glycemic control in patients with type II diabetes mellites on polypharmacy over a period of 12 weeksTimepoint: The overall duration of the study will be for 12 weeks, and the patient will be asked to come for follow up at the end of 4th, 8th, and 12th week.—

Secondary

MeasureTime frame
1. To assess the effect of intermittent fasting on glycemic control in pre-diabetic patients over a period of 12 weeks 2. To determine the post intermittent fasting reduction in medication in patients of diabetes mellitus on polypharmacy prescription. 3. To assess the effect of intermittent fasting on biochemical parameters in pre-diabetic patients over a period of 12 weeks 4. To assess the adverse reaction in patients of diabetes mellitus undergoing intermittent fasting over a period of 12 weeks Timepoint: 12 weeks—

Countries

India

Contacts

Public ContactDr Syed Shariq Naeem

Jawaharlal Nehru Medical College, Aligarh Muslim University.

syedshariq1@gmail.com9634912166

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026